As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
The Top Three Pathogens to Worry About in 2026
Blackbird Health Opens New Pediatric Mental Health Clinic in Virginia
Baptist Medical Center Jacksonville to Get Inpatient Rehabilitation Unit
Building Envelopes Emerge As Key Facility Components
Catholic Medical Center Breaks Ground on New Central Energy Plant